Echocardiographic Predictors of Atrial Fibrillation

Recruiting

Back to Atrial Fibrillation trials

Trial locations(1 site)

Austria

University Hospital Tulln, Tulln

Key details

Sponsor

Karl Landsteiner University of Health Sciences

Collaborators

NÖ Landesgesundheitsagentur, legal entity of University Hospitals in Lower Austria, Department of Internal Medicine, University Hospital Tulln, Alter Ziegelweg 10, 3430, Tulln, Austria

Enrollment target

~200 participants

Started

January 2021

Primary completion

November 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated March 2023